• Increase font size
  • Default font size
  • Decrease font size

GSK and Theravance Announce Completion of the Relovair(TM)* Registrational Programme; Amylin Announces BYETTA European Approval

Print E-mail
Written by Staff and Wire Reports   
Friday, 23 March 2012 19:20
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 23, 2012.
Read more...
 

Chance to discover and help fund top innovators in healthcare early intrigues investors

Print E-mail
Written by Staff and Wire Reports   
Friday, 23 March 2012 07:48
They may be some of the most talked about market movers today, but companies like Alimera Sciences (Nasdaq:ALIM), Pozen (Nasdaq:POZN), Threshold Pharmaceuticals (Nasadq: THLD), Arena Pharmaceuticals (Nasdaq:ARNA) and others were once only ideas looking for early investors to back and believe in them.
Read more...
 

Impressive development programs, partnerships and product launch prep appear to make IntelGenX a solid bet at these prices

Print E-mail
Written by M.E.Garza   
Friday, 23 March 2012 06:00
Shares of IntelGenX Corporation (OTCBB: IGXT) were trading just under $.50 per share last November. That was the first time we told our readers the relatively under-followed story a micro-cap biotech with a pending FDA decision that could become a game changer for the company focused on improving existing medications by incorporating proprietary, advanced controlled-release technologies.
Read more...
 

POZEN Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies; Endocyte Receives USAN Approval for Nonproprietary

Print E-mail
Written by Staff and Wire Reports   
Thursday, 22 March 2012 17:33
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 22, 2012.
Read more...
 

Beware: Highly Promoted Galena Biopharma Keeps Moving Higher

Print E-mail
Written by Michael Morhamus, Contributor   
Thursday, 22 March 2012 13:42
Last December, I warned investors to be cautious of CytRx Corporation (CYTR) and any deal or off-spring company related to them.  Now this.
Read more...
 

Choose Medical Technology Stocks Carefully: William Plovanic

Print E-mail
Written by George S. Mack of The Life Sciences Report   
Thursday, 22 March 2012 03:59
The dart board will not help in picking medical technology stocks. Analyst and Managing Director William Plovanic of Canaccord Genuity focuses on the musculoskeletal/orthopedic sector, which is sensitive to factors beyond just the unmet needs of patients. 
Read more...
 

J&J Marketed Mesh Implant Without U.S. Approval; Align Announces Shareholder Lawsuit Dismissed

Print E-mail
Written by Staff and Wire Reports   
Wednesday, 21 March 2012 19:59
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 21, 2012.
Read more...
 

Pluristem Therapeutics' Plant Scale-up And and New Heart Tissue Data Signal Buy Opportunity

Print E-mail
Written by Ray Dirks of Ray Dirks Research   
Wednesday, 21 March 2012 00:39
Given some recent news, volume and interest are returning to Pluristem Therapeutics (NASDAQ:PSTI), creator of regenerative medicine based on stem cells that come from the human placenta. Once again, the stock is starting to move again.
Read more...
 

CEL-SCI break-out appears fundamental in nature

Print E-mail
Written by Michael Morhamus, Contributor   
Wednesday, 21 March 2012 00:00
Shares of Virginia based biotechnology company, CEL-SCI Corporation (AMEX: CVM) appear to be technically breaking out to the upside again. Interest and volume in the stock has been on the rise and some recent fundamental developments appear to be fuelling the price rise.
Read more...
 

Eli Lilly to Focus on Cancer, Diabetes in China; Pfizer’s Rheumatoid Arthritis Pill: Not A Slam Dunk

Print E-mail
Written by Staff and Wire Reports   
Tuesday, 20 March 2012 18:58
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 20, 2012.
Read more...
 
<< Start < 1 2 3 4 5 6 7 9 > End >>

Page 9 of 237
about 6 minutes ago $AMLN Said to Attract Interest From Pfizer, AstraZeneca - Businessweek http://t.co/PFKT6LE8
about 48 minutes ago Stock Market: Stocks Extend Losing Streak http://t.co/ZmZxvJiO
about 2 hours ago Cancer Survivors Who Exercise Live Longer http://t.co/U4MhX04a
about 3 hours ago Colon cancer screenings that don’t require laxatives are almost as effective as colonoscopies and may encourage more tests http://j.m
about 4 hours ago Testing a Drug That May Stop Alzheimer’s Before It Starts $RHHBY http://t.co/Wjgw15IS
about 4 hours ago Two patients get eye stem cells transplanted to restore sight http://t.co/HHYZlFFT
about 4 hours ago US Senate call to scrap drug patents: http://t.co/W1BOuxJp
about 4 hours ago http://t.co/MAgh4Xke

navigation

Free Phone Trade Alerts

Benzinga.com supporter Seeking Alpha Certified